ATE511657T1 - Bestimmungsverfahren für equine nt-probnp. - Google Patents

Bestimmungsverfahren für equine nt-probnp.

Info

Publication number
ATE511657T1
ATE511657T1 AT08714281T AT08714281T ATE511657T1 AT E511657 T1 ATE511657 T1 AT E511657T1 AT 08714281 T AT08714281 T AT 08714281T AT 08714281 T AT08714281 T AT 08714281T AT E511657 T1 ATE511657 T1 AT E511657T1
Authority
AT
Austria
Prior art keywords
probnp
equine
determination method
determination
Prior art date
Application number
AT08714281T
Other languages
English (en)
Inventor
Wolfgang Woloszczuk
Gerhard Hawa
Original Assignee
Biomedica Medizinprodukte Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica Medizinprodukte Gmbh & Co Kg filed Critical Biomedica Medizinprodukte Gmbh & Co Kg
Application granted granted Critical
Publication of ATE511657T1 publication Critical patent/ATE511657T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
AT08714281T 2007-03-07 2008-03-07 Bestimmungsverfahren für equine nt-probnp. ATE511657T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0036507A AT504942B1 (de) 2007-03-07 2007-03-07 Verfahren zur bestimmung von probnp
PCT/AT2008/000084 WO2008106707A1 (en) 2007-03-07 2008-03-07 Method of determining nt-probnp

Publications (1)

Publication Number Publication Date
ATE511657T1 true ATE511657T1 (de) 2011-06-15

Family

ID=39496060

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0036507A AT504942B1 (de) 2007-03-07 2007-03-07 Verfahren zur bestimmung von probnp
AT08714281T ATE511657T1 (de) 2007-03-07 2008-03-07 Bestimmungsverfahren für equine nt-probnp.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0036507A AT504942B1 (de) 2007-03-07 2007-03-07 Verfahren zur bestimmung von probnp

Country Status (8)

Country Link
US (1) US9103839B2 (de)
EP (1) EP2118668B1 (de)
CN (1) CN101627310A (de)
AT (2) AT504942B1 (de)
AU (1) AU2008222578B2 (de)
CA (1) CA2678465A1 (de)
ES (1) ES2364942T3 (de)
WO (1) WO2008106707A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778699B2 (en) 2010-08-04 2014-07-15 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US8481333B2 (en) 2011-05-31 2013-07-09 Idexx Laboratories, Inc. Detection of degradation products of feline NT-proBNP
CN102854321B (zh) * 2012-07-26 2015-09-02 博奥赛斯（天津）生物科技有限公司 N末端b型脑钠肽前体化学发光免疫定量检测试剂盒及其制备方法
CN104714025B (zh) * 2014-11-28 2017-05-17 威海纽普生物技术有限公司 NT‑proBNP检测试剂盒及检测方法
CN108254559A (zh) * 2018-01-03 2018-07-06 北京市理化分析测试中心 快速检测微生物的方法
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
CN109678958B (zh) * 2019-01-31 2022-03-18 重庆探生科技有限公司 一种人NT-proBNP特异性重组羊单克隆抗体及其制备方法和应用
CN112321710A (zh) * 2020-09-21 2021-02-05 嘉兴朝云帆生物科技有限公司 一种猫n-端脑利钠肽前体蛋白的单克隆抗体及制备和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
CA2248140C (en) * 1996-03-04 2005-02-01 Ronald P. Mischak Assay and reagents for quantifying hbnp
JP3516655B2 (ja) 1997-09-11 2004-04-05 塩野義製薬株式会社 Ｂｎｐの免疫測定法
DK1100830T3 (da) 1998-07-28 2004-01-19 Micromet Ag Heterominiantistoffer
GB9827348D0 (en) 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
US6492127B2 (en) 2001-01-23 2002-12-10 Varian, Inc. Lateral flow testing device with on-board chemical reactant
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
FR2843396B1 (fr) 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US20040096919A1 (en) 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides

Also Published As

Publication number Publication date
ES2364942T3 (es) 2011-09-19
CA2678465A1 (en) 2008-09-12
WO2008106707A1 (en) 2008-09-12
AU2008222578A1 (en) 2008-09-12
AT504942A1 (de) 2008-09-15
EP2118668A1 (de) 2009-11-18
AU2008222578B2 (en) 2012-11-29
US9103839B2 (en) 2015-08-11
CN101627310A (zh) 2010-01-13
EP2118668B1 (de) 2011-06-01
AT504942B1 (de) 2009-08-15
US20100136590A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
ATE511657T1 (de) Bestimmungsverfahren für equine nt-probnp.
BRPI0814466A2 (pt) Método.
BRPI0819127A2 (pt) Método para cimentar.
BRPI0813569A2 (pt) Método de inspeção.
EP2376105A4 (de) Nkg2d-fc für immuntherapie
BRPI0919841A2 (pt) Anticorpo de cadeia unica biespecifico de psmaxcd3, especifico de especies cruzadas
EP2009611A4 (de) Detektor für strassentrennlinie
FI20075800L (fi) Menetelmä LNG-käyttöisen vesialuksen käyttämiseksi
BRPI0817402A2 (pt) dispositivos e métodos para automação de fluxos de trabalho, adaptação e integração
BRPI0922208A2 (pt) método de mineração de minerio.
CL2008000325S1 (es) Automovil.
CL2008000782S1 (es) Automovil.
EP2142865A4 (de) Steuerverfahren für kühlschrank
BRPI0918736A2 (pt) método para produzir leite modificado.
CL2008000916S1 (es) Automovil.
DE602006010105D1 (de) Bedarfsgesteuerter auto-tuner für ein anlagesteuersystem
BRPI0813366A2 (pt) Método para executar uma combustão.
EP2163464A4 (de) Sattelfahrzeug
EP2310214A4 (de) Seitenwandmerkmale für reifen
DE602006014117D1 (de) Antriebssystem für landeklappe
DE602008000495D1 (de) Verbindungsverfahren für Werkstücke
NL1036308A1 (nl) Lithographic method.
FI20070538A0 (fi) Menetelmä la laite mobiilibroadcastin luotettavuuden parantamiseksi
NL2002886A1 (nl) Prognostic method.
DE602006017336D1 (de) Prozessverbindung für prozessdiagnostik

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties